Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis - Bernard, G.R.; Vincent, J.L.; Laterre, P.F (N Engl J Med, 2001)
et al.